<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>ANTIBODY</title><link>https://www.spreaker.com/podcast/antibody--3568852</link><description><![CDATA[]]></description><atom:link href="https://www.spreaker.com/show/3568852/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Health &amp; Fitness</category><copyright>Copyright echo han</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg</url><title>ANTIBODY</title><link>https://www.spreaker.com/podcast/antibody--3568852</link></image><lastBuildDate>Fri, 02 Jul 2021 06:59:28 +0000</lastBuildDate><itunes:author>echo han</itunes:author><itunes:owner><itunes:name>echo han</itunes:name><itunes:email>feeds@spreaker.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:category text="Health &amp; Fitness"/><itunes:explicit>clean</itunes:explicit><itunes:type>episodic</itunes:type><item><title>Antibody based Cancer Therapies</title><link>https://www.spreaker.com/episode/antibody-based-cancer-therapies--45540487</link><description><![CDATA[Secondary antibodies should be raised based upon the primary antibody you are using that produced by different host species. If your primary antibody is a mouse monoclonal, the secondary antibody should be an anti-mouse Ab. Similarly, a rabbit monoclonal primary antibody will correspond to an anti-rabbit secondary Ab. In addition, secondary antibodies conjugated to fluorochromes and chromogens depend on your project requirements.<a href="https://www.antibody-creativebiolabs.com/technical-faqs.htm" rel="noopener">https://www.antibody-creativebiolabs.com/technical-faqs.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540487</guid><pubDate>Fri, 02 Jul 2021 06:59:28 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540487/antibody_based_cancer_therapies_creative_biolabs.mp3" length="12126838" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>Secondary antibodies should be raised based upon the primary antibody you are using that produced by different host species. If your primary antibody is a mouse monoclonal, the secondary antibody should be an anti-mouse Ab. Similarly, a rabbit...</itunes:subtitle><itunes:summary><![CDATA[Secondary antibodies should be raised based upon the primary antibody you are using that produced by different host species. If your primary antibody is a mouse monoclonal, the secondary antibody should be an anti-mouse Ab. Similarly, a rabbit monoclonal primary antibody will correspond to an anti-rabbit secondary Ab. In addition, secondary antibodies conjugated to fluorochromes and chromogens depend on your project requirements.<a href="https://www.antibody-creativebiolabs.com/technical-faqs.htm" rel="noopener">https://www.antibody-creativebiolabs.com/technical-faqs.htm</a>]]></itunes:summary><itunes:duration>758</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>An Overview of Prostate Cancer</title><link>https://www.spreaker.com/episode/an-overview-of-prostate-cancer--45540486</link><description><![CDATA[Prostate cancer (PCa) is the second leading cause of cancer death in American men, behind lung cancer and it predominately affects elderly men with higher incidence. About 1 man in 41 will die of prostate cancer. The development of PCa involves several mutations in prostate epithelial cells, usually linked to developmental changes, such as enhanced resistance to apoptotic death, constitutive proliferation, and, in some cases, to differentiation into an androgen deprivation-resistant phenotype, leading to the appearance of castration-resistant PCa (CRPCa), which leads to a poor prognosis in patients.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-IGG.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-IGG.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540486</guid><pubDate>Fri, 02 Jul 2021 06:58:24 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540486/an_overview_of_prostate_cancer_creative_biolabs.mp3" length="10916846" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>Prostate cancer (PCa) is the second leading cause of cancer death in American men, behind lung cancer and it predominately affects elderly men with higher incidence. About 1 man in 41 will die of prostate cancer. The development of PCa involves...</itunes:subtitle><itunes:summary><![CDATA[Prostate cancer (PCa) is the second leading cause of cancer death in American men, behind lung cancer and it predominately affects elderly men with higher incidence. About 1 man in 41 will die of prostate cancer. The development of PCa involves several mutations in prostate epithelial cells, usually linked to developmental changes, such as enhanced resistance to apoptotic death, constitutive proliferation, and, in some cases, to differentiation into an androgen deprivation-resistant phenotype, leading to the appearance of castration-resistant PCa (CRPCa), which leads to a poor prognosis in patients.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-IGG.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-IGG.htm</a>]]></itunes:summary><itunes:duration>683</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>An Overview of Endometrial Cancer</title><link>https://www.spreaker.com/episode/an-overview-of-endometrial-cancer--45540485</link><description><![CDATA[Endometrial cancer (EC) is the most common gynecologic malignancy. It is the fourth most common cancer in women in the United States after breast, lung, and colorectal cancers.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-dsDNA.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-dsDNA.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540485</guid><pubDate>Fri, 02 Jul 2021 06:57:29 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540485/an_overview_of_endometrial_cancer_creative_biolabs.mp3" length="8591740" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>Endometrial cancer (EC) is the most common gynecologic malignancy. It is the fourth most common cancer in women in the United States after breast, lung, and colorectal cancers.https://www.antibody-creativebiolabs.com/symbolsearch-dsDNA.htm</itunes:subtitle><itunes:summary><![CDATA[Endometrial cancer (EC) is the most common gynecologic malignancy. It is the fourth most common cancer in women in the United States after breast, lung, and colorectal cancers.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-dsDNA.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-dsDNA.htm</a>]]></itunes:summary><itunes:duration>537</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>An Introduction to Thyroid Cancer</title><link>https://www.spreaker.com/episode/an-introduction-to-thyroid-cancer--45540484</link><description><![CDATA[Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality has increased steadily over the last four decades.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-DNA.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-DNA.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540484</guid><pubDate>Fri, 02 Jul 2021 06:56:49 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540484/an_introduction_to_thyroid_cancer_creative_biolabs.mp3" length="7638375" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality has increased steadily over the last four decades.https://www.antibody-creativebiolabs.com/symbolsearch-DNA.htm</itunes:subtitle><itunes:summary><![CDATA[Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality has increased steadily over the last four decades.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-DNA.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-DNA.htm</a>]]></itunes:summary><itunes:duration>478</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>An Overview of Pancreatic Cancer</title><link>https://www.spreaker.com/episode/an-overview-of-pancreatic-cancer--45540483</link><description><![CDATA[Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration and low surgical resection rate in the digestive system, ranking third in cancer-related deaths in the United States.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-TPO.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-TPO.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/45540483</guid><pubDate>Fri, 02 Jul 2021 06:56:10 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/45540483/an_overview_of_pancreatic_cancer_creative_biolabs.mp3" length="14543896" type="audio/mpeg"/><itunes:author>echo han</itunes:author><itunes:subtitle>Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration and low surgical resection rate in the digestive system, ranking third in cancer-related deaths in the United...</itunes:subtitle><itunes:summary><![CDATA[Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration and low surgical resection rate in the digestive system, ranking third in cancer-related deaths in the United States.<a href="https://www.antibody-creativebiolabs.com/symbolsearch-TPO.htm" rel="noopener">https://www.antibody-creativebiolabs.com/symbolsearch-TPO.htm</a>]]></itunes:summary><itunes:duration>909</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--Jk1mRJJ6--/w_1000,h_800,c_fit,l_text:Lato_172_bold:ANTIBODY/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
